Pure Global

Impact of Augmenting Exercise Intensity vs. Frequency - Trial NCT04295590

Access comprehensive clinical trial information for NCT04295590 through Pure Global AI's free database. This phase not specified trial is sponsored by Brendon Gurd, PhD and is currently status unknown. The study focuses on Exercise Training. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04295590
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT04295590
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Impact of Augmenting Exercise Intensity vs. Frequency
Impact of Augmenting Exercise Intensity vs. Frequency on Peak Work Rate

Study Focus

Exercise Training

Frequency comparison

Interventional

behavioral

Sponsor & Location

Brendon Gurd, PhD

Queen's University

Kingston, Canada

Timeline & Enrollment

N/A

Sep 30, 2019

Apr 10, 2020

16 participants

Primary Outcome

Peak work rate

Summary

The purpose of this study is to compare the impact of augmenting exercise intensity and
 augmenting exercise frequency on peak work rate. Participants will complete exercise tests
 and provide 8 skeletal muscle samples following a within-subjects randomized crossover design
 utilizing single-leg cycling. Both training periods will be 4 weeks long and skeletal muscle
 biopsies will be collected from both legs before and after each training period. All exercise
 sessions will be supervised, take place in the investigator's laboratory, and occur on
 stationary bikes.

ICD-10 Classifications

Orthoptic training
Lack of physical exercise
Other physical therapy
Cardiac rehabilitation
Exhaustion due to excessive exertion

Data Source

ClinicalTrials.gov

NCT04295590

Non-Device Trial